Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€71.49

€71.49

-13.720%
-11.39
-13.720%
-
 
30.04.24 / Tradegate WKN: A3D3G6 / Name: Ge Healthcare Technologies Inc / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Ge Healthcare Technologies Inc Stock

Ge Healthcare Technologies Inc took a tumble today and lost -€11.390 (-13.720%).

Pros and Cons of Ge Healthcare Technologies Inc in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress: https://mms.businesswire.com/media/20230105005172/en/1673594/5/GE_HealthCare_Logo_%28Jan_2023%29.jpg
GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress


GE HealthCare (Nasdaq: GEHC) today announced Revolution RT,i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging

GE HealthCare Reports First Quarter 2024 Financial Results: https://mms.businesswire.com/media/20230105005172/en/1673594/5/GE_HealthCare_Logo_%28Jan_2023%29.jpg
GE HealthCare Reports First Quarter 2024 Financial Results


GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today reported financial results for the first quarter ended March 31, 2024.



GE HealthCare President and CEO Peter

GE HealthCare Receives FDA Clearance for Portrait VSM, Building on Its Growing Ecosystem of Connected Patient Monitoring Solutions: https://mms.businesswire.com/media/20240429837183/en/2111191/5/Portrait_VSM_Image_%283%29.jpg
GE HealthCare Receives FDA Clearance for Portrait VSM, Building on Its Growing Ecosystem of Connected Patient Monitoring Solutions


GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait VSM vital signs monitor that can provide